Röntgeninstitut Aarau has been acquired by Evidia
August 2026 — The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.
Founded in 1978, Röntgeninstitut Aarau is an established outpatient radiology practice in the center of Aarau, Switzerland. With an experienced team of physicians, the institute offers a comprehensive range of modern diagnostic imaging services.
Evidia is a leading European provider of radiology, nuclear medicine and radiotherapy services, operating a network of practices across Germany, Sweden, Norway and the UK. The group is backed by private equity firm EQT.
Our role in the transaction
Oaklins acted as the exclusive M&A advisor to the owners of Röntgeninstitut Aarau, conducting a structured approach involving selected strategic and financial investors. The team guided the owners throughout the process, from positioning and investor outreach through due diligence to the negotiation of key commercial terms and the successful closing of the transaction.
Dr. Herbert Wegmüller and Dr. Thierry Littmann
Owners, Röntgeninstitut Aarau
Contacter l'équipe de la transaction
Christian Ernst
Oaklins Germany
Florian Mattern
Oaklins Switzerland
Transactions connexes
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
En apprendre plusLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
En apprendre plus